MicroRNA-107: A novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma

Oncotarget

Volumn 7, Issue 1, 2016, Pages 266-278

  Zou, Chen Dan ^a   Zhao, Wei Ming ^a   Wang, Xiao Na ^a   Li, Qiang ^b   Huang, Hui ^a   Cheng, Wan Peng ^a   Jin, Jian Feng ^a   Zhang, He ^a   Wu, Ming Juan ^c   Tai, Sheng ^b   Zou, Chao Xia ^a   Gao, Xu ^a,d  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c Heilongjiang Academy of Traditional Chinese Medicine   (China)

^d Biopharmaceutical Institute   (China)

Author keywords

CPEB3; EGFR; Hepatocellular carcinoma; MicroRNA; MicroRNA 107

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA 107; 3' UNTRANSLATED REGION; CPEB3 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; MICRORNA; MIRN107 MICRORNA, HUMAN; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CPEB3 GENE; DRUG TARGETING; EGFR GENE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; TUMOR SUPPRESSOR GENE; 3' UNTRANSLATED REGION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-BINDING PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84969556572     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/ONCOTARGET.5689     Document Type: Article

References (37)

1. Belghiti J, Fuks D. Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer. 2012; 1:71-82
2. El-Serag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132:2557-2576
3. Llovet J M, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008; 48:S20-37
4. Forner A, Hessheimer A J, Isabel Real M, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2006; 60:89-98
5. Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe S W. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 2008; 22:1439-1444
6. Han L L, Nan H C, Tian T, Guo H, Hu T H, Wang W J, Ma J Q, Jiang L L, Guo Q Q, Yang C C, Kang X M, Liu Y, Gao Y, et al. Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma. Oncol Rep. 2014; 31:2569-2578
7. Han C, Yu Z, Duan Z, Kan Q. Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014; 2014:428371
8. Bartel D P. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233
9. Volonte C, Apolloni S, Parisi C. MicroRNAs: Newcomers into the ALS Picture. CNS Neurol Disord Drug Targets. 2015; 14:194-207
10. Song S J, Poliseno L, Song M S, Ala U, Webster K, Ng C, Beringer G, Brikbak N J, Yuan X, Cantley L C, Richardson A L, PandolfiP P. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell. 2013; 154:311-324
11. Hua H W, Jiang F, Huang Q, Liao Z, Ding G. MicroRNA-153 promotes Wnt/beta-catenin activation in hepatocellular carcinoma through suppression of WWOX. Oncotarget. 2015; 6:3840-3847. doi: 10.18632/oncotarget.2927
12. Yan S Y, Chen M M, Li G M, Wang Y Q, Fan J G. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. Tumour Biol. 2015; doi 10.1007/s13277-015-3124-9. [Epub ahead of print]
13. Schutte K, Schulz C, Link A, Malfertheiner P. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. World J Hepatol. 2015; 7:139-149
14. Jiang Z P, Zhou T B. Role of miR-107 and its signaling pathways in diseases. J Recept Signal Transduct Res. 2014; 34:338-341
15. Zhang Z, Zhang L, Yin Z Y, Fan X L, Hu B, Wang L Q, Zhang D. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Int J Clin Exp Pathol. 2014; 7:7236-7241
16. Molina-Pinelo S, Carnero A, Rivera F, Estevez-Garcia P, Bozada J M, Limon M L, Benavent M, Gomez J, Pastor M D, Chaves M, Suarez R, Paz-Ares L, De La Portilla F, et al. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer. BMC Cancer. 2014; 14:656
17. Huang Y S, Dai Y, Yu X F, Bao S Y, Yin Y B, Tang M, Hu C X. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol. 2008; 23:87-94
18. D'ambrogio A, Nagaoka K, Richter J D. Translational control of cell growth and malignancy by the CPEBs. Nat Rev Cancer. 2013; 13:283-290
19. Peng S C, Lai Y T, Huang H Y, Huang H D, Huang Y S. A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons. Nucleic Acids Res. 2010; 38:7446-7457
20. Wang C F, Huang Y S. Calpain 2 activated through N-methyl-D-aspartic acid receptor signaling cleaves CPEB3 and abrogates CPEB3-repressed translation in neurons. Mol Cell Biol. 2012; 32:3321-3332
21. Chu T H, Chan H H, Kuo H M, Liu L F, Hu T H, Sun C K, Kung M L, Lin S W, Wang E M, Ma Y L, Cheng K H, Lai K H, Wen Z H, et al. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget. 2014; 5:1475-1490. doi: 10.18632/oncotarget.1745
22. Sapisochin G, De Sevilla E F, Echeverri J, Charco R. Management of 'very early' hepatocellular carcinoma on cirrhotic patients. World J Hepatol. 2014; 6:766-75
23. Aravalli R N, Steer C J, Cressman E N. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008; 48:2047-2063
24. Van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009; 5:1169-1179
25. Chang R M, Yang H, Fang F, Xu J F, Yang L Y. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 2014; 60:1251-1263
26. Wang F, Ying H Q, He B S, Pan Y Q, Deng Q W, Sun H L, Chen J, Liu X, Wang S K. Upregulated lncRNAUCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015; 6:7899-7917. doi:10.18632/oncotarget.3219
27. Song Y Q, Ma X H, Ma G L, Lin B, Liu C, Deng Q J, Lv W P. MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8. Diagn Pathol. 2014; 9:164
28. Zhou C, Li G, Zhou J, Han N, Liu Z, Yin J. miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1. PLoS One. 2014; 9:e111860
29. Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer. 2015; 6:6977-6988
30. Mendez R, Richter J D. Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol. 2001; 2:521-529
31. Charlesworth A, Meijer H A, De Moor C H. Specificity factors in cytoplasmic polyadenylation. Wiley Interdiscip Rev RNA. 2013; 4:437-461
32. Novoa I, Gallego J, Ferreira P G, Mendez R. Mitotic cellcycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol. 2010; 12:447-456
33. Bava F A, Eliscovich C, Ferreira P G, Minana B, Ben-Dov C, Guigo R, Valcarcel J, Mendez R. CPEB1 coordinates alternative 3'-UTR formation with translational regulation. Nature. 2013; 495:121-125
34. Ortiz-Zapater E, Pineda D, Martinez-Bosch N, Fernandez-Miranda G, Iglesias M, Alameda F, Moreno M, Eliscovich C, Eyras E, Real F X, Mendez R, Navarro P. Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med. 2012; 18:83-90
35. Vetere G, Barbato C, Pezzola S, Frisone P, Aceti M, Ciotti M, Cogoni C, Ammassari-Teule M, Ruberti F. Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory. Hippocampus. 2014; 24:1458-1465
36. Berasain C, Avila M A. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol. 2014; 49:9-23
37. Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H, Wang W, Zhang L, Zhang X, Tang Q, Zhang C, Tao J, Wang X, Gao X. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett. 2013; 335:168-174